India's Biocon unit approves transfer of branded formulations biz to Eris Lifesciences
BENGALURU, March 14 (Reuters) - Indian biopharmaceutical company Biocon BION.NS said on Thursday its unit Biocon Biologics approved the transfer of businesses related to its branded formulations in the country to Eris Lifesciences ERIS.NS . (Reporting by Varun Vyas in Bengaluru; Editing by Janane Venkatraman ) ((varunvyas.hebbalalu@thomsonreuters.com;))
Recent news on Eris Lifesciences
See all newsIndia's Eris Lifesciences gains on strong quarterly results
Brief: Eris Lifesciences Sept-Quarter Consol Net Profit 1.84 Billion Rupees
Brief: Eris Lifesciences Says Krishnakumar Vaidyanathan Resigns As Executive Director & COO
Brief: Eris Lifesciences Ltd Says June-Quarter Consol Net Profit 1.42 Billion Rupees
Brief: Eris Lifesciences March-Quarter Consol Net Profit 2.82 Billion Rupees